Blue Flower

Ohiio Patitent Network has submitted a petition as passed by Ohio's Medical Marijuana law HB523 and as defined by the Ohio Medical Board (OMB) rules to add a qualifying condition.  The rules laid out 5 requirements to be submitted;  they are as follows

  1. Information from experts who specialize in the disease or condition
  2. Relevant medical or scientific evidence pertaining to the disease or condition
  3. Consideration of whether conventional medical therapies are insufficient to treat or alleviate the disease or condition
  4. Evidence supporting the use of medical marijuana to treat or alleviate the disease or condition, including journal articles, peer-reviewed studies, and other types of medical or scientific documentation
  5. Letters of support provided by physicians with knowledge of the disease or condition.

We addressed each requirement in exacting detail and share them with you below.

  • Information from experts who specialize in the disease or condition

Opioid Use Disorder/Opioid Addiction is the physical and psychological reliance on opioids found in prescription pain medications and illegal drugs like heroin and fentanyl derivatives. Addiction occurs when dependence interferes with daily life. Symptoms include uncontrollable cravings and inability to control opioid use. People may experience whole body craving, sweating, euphoria or general angst. Some common effects are constipation, nausea, and death due to overdose. See complete response at http://www.ohiopatientsnetwork.org/Data/Petition/Section_1.pdf

  • Relevant medical or scientific evidence pertaining to the disease or condition

Included in the attached Section 2 PDF file is a variety of government reports detailing the relevant medical evidence of Opioid Use Disorder with reference links to the original reports.  The documents address the scope and the science of addiction, including a commentary by Nora D. Volkow, M.D., Director, NIDA and more. The attachment also includes the most recent report from the National Center for Health Statistics listing Ohio as the second highest in the nation for overdose.  See complete response at http://www.ohiopatientsnetwork.org/Data/Petition/Section_2.pdf

  • Consideration of whether conventional medical therapies are insufficient to treat or alleviate the disease or condition

Opioid Use Disorder is a complex condition that is not easily treated successfully.  The patient usually has other associated mental and/or physical issues.   According to NIDA the relapse rate for patients going through drug addiction treatment ranges from 40% to 60%.  Twelve Step Facilitation programs have mixed success and are not well documented. The indisputable fact that we have such a tremendous number of overdose deaths indicates that conventional medical therapies are insufficient. See complete response at http://www.ohiopatientsnetwork.org/Data/Petition/Section_3.pdf

  • Evidence supporting the use of medical marijuana to treat or alleviate the disease or condition, including journal articles, peer-reviewed studies, and other types of medical or scientific documentation.

In New York and Illinois, doctors can recommend medical marijuana for conditions where they prescribe an opioid. Pennsylvania & New Jersey permit patients to use medical marijuana for Opioid Use Disorder. Studies show significant reduction in opioid prescriptions in states with marijuana states vs non marijuana states. In the numerous JAMA articles you can find reports that links medical marijuana to reduction in risk of opioid overdose and increased treatment retention. See complete response at http://www.ohiopatientsnetwork.org/Data/Petition/Section_4.pdf

  • Letters of support provided by physicians with knowledge of the disease or condition.

Included in this section are PDF copies of 7 physicians’ letters supporting adding Opioid Use Disorder/Opiate Addiction as a qualifying condition. One is from Dr. Ethan Russo, a neurologist with drug development experiences and leadership positions in international research medical organizations. Dr. Blatman is an Ohio based pain practitioner and Dr. Sawyer is certified in Suboxone therapy. Dr. Kollman was co-author of the American Legion National 2017 Resolution that changed the policy towards medical marijuana in Veterans Administration Medical Facilities. Also included are three more Ohio Licensed physicians.  All the physicians’ medical licenses have been independently verified and clear of any blemishes or negative reports.  See Complete response at http://www.ohiopatientsnetwork.org/Data/Petition/Section_5.pdf